Newbridge Financial Services Group, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Newbridge Financial Services Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$14.14 - $23.06 $14,140 - $23,060	-1,000 Reduced 40.0%	1,500 $0
Q3 2022 Oct 13, 2022	SELL	$13.05 - $22.13 $835 - $1,416	-64 Reduced 2.5%	2,500 $37,000
Q2 2022 Jul 15, 2022	SELL	$12.26 - $31.17 $6,130 - $15,585	-500 Reduced 16.32%	2,564 $40,000
Q1 2022 Apr 26, 2022	SELL	$17.64 - $39.57 $14,994 - $33,634	-850 Reduced 21.72%	3,064 $83,000
Q4 2021 Jan 19, 2022	SELL	$34.2 - $47.56 $6,840 - $9,512	-200 Reduced 4.86%	3,914 $145,000
Q3 2021 Oct 27, 2021	BUY	$27.88 - $58.25 $107,338 - $224,262	3,850 Added 1458.33%	4,114 $197,000
Q1 2021 Sep 07, 2021	SELL	$38.75 - $86.92 $12,748 - $28,596	-329 Reduced 55.48%	264 $11,000
Q4 2020 Sep 07, 2021	BUY	$34.61 - $123.66 $17,305 - $61,830	500 Added 537.63%	593 $26,000
Q3 2020 Sep 07, 2021	BUY	$37.49 - $63.19 $3,486 - $5,876	93 New	93 $4,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.